OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2023
(2)
2016
(2)
2022
(1)
2019
(1)
2018
(1)
2017
(1)
2014
(1)
2011
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Scalable Preparation of Enantioenriched (S)-5-methylhept-2-en-4-one. Synthesis and Aroma Properties of Achiral Analogues Thereof.
Not available
S-EPMC6943495
|
biostudies-literature
Cite
Aroma Compounds in Essential Oils: Analyzing Chemical Composition Using Two-Dimensional Gas Chromatography-High Resolution Time-of-Flight Mass Spectrometry Combined with Chemometrics.
Not available
S-EPMC10305201
|
biostudies-literature
Cite
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics.
Not available
S-EPMC8910891
|
biostudies-literature
Cite
Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
Not available
S-EPMC5400624
|
biostudies-literature
Cite
βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors.
Not available
S-EPMC6215644
|
biostudies-literature
Cite
Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Not available
S-EPMC4751222
|
biostudies-literature
Cite
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
Not available
S-EPMC4260030
|
biostudies-literature
Cite
The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naive patients with germ cell cancer.
Not available
S-EPMC5342793
|
biostudies-literature
Cite
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs.
Not available
S-EPMC10202799
|
biostudies-literature
Cite
Adjuvant trastuzumab in HER2-positive breast cancer.
Not available
S-EPMC3268553
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets